scanance.
Sign inGet Premium
CC

The Chemours Company

CCBasic MaterialsNASDAQ

Specialty Chemicals

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$5.81B
+0.4% YoY
Net Income
-$386.0M
-659.4% YoY
EBITDA
$332.0M
-49.8% YoY
Free Cash Flow
$216.3M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About The Chemours Company

Headquartered within the basic materials sector, The Chemours Company focuses on Specialty Chemicals services and products. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The $3.36B market capitalization puts CC squarely in mid-cap range for its industry. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.

Key stats
Market Cap$3.36B
Fwd P/E9.87
EPS$-2.73
Beta1.46
52W Change+124.8%
Dividend Yield1.57%
ROE-103.0%
Analysis

On the balance sheet, CC has $563.0M in cash with $4.39B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $216.2M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -103.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $6.34B (2021) to $5.81B (2025).

The Chemours Company carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for The Chemours Company and its sector.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms